» Articles » PMID: 26292315

Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study

Abstract

Quantitative PCR (qPCR) analysis of human T-cell leukemia virus type 1 (HTLV-1) was used to assess the amount of HTLV-1 provirus DNA integrated into the genomic DNA of host blood cells. Accumulating evidence indicates that a high proviral load is one of the risk factors for the development of adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis. However, interlaboratory variability in qPCR results makes it difficult to assess the differences in reported proviral loads between laboratories. To remedy this situation, we attempted to minimize discrepancies between laboratories through standardization of HTLV-1 qPCR in a collaborative study. TL-Om1 cells that harbor the HTLV-1 provirus were serially diluted with peripheral blood mononuclear cells to prepare a candidate standard. By statistically evaluating the proviral loads of the standard and those determined using in-house qPCR methods at each laboratory, we determined the relative ratios of the measured values in the laboratories to the theoretical values of the TL-Om1 standard. The relative ratios of the laboratories ranged from 0.84 to 4.45. Next, we corrected the proviral loads of the clinical samples from HTLV-1 carriers using the relative ratio. As expected, the overall differences between the laboratories were reduced by half, from 7.4-fold to 3.8-fold on average, after applying the correction. HTLV-1 qPCR can be standardized using TL-Om1 cells as a standard and by determining the relative ratio of the measured to the theoretical standard values in each laboratory.

Citing Articles

Evaluation of human T-cell leukemia virus in vitro diagnostics using plasma specimens collected in Japan.

Kusagawa S, Kawana-Tachikawa A, Matsubayashi K, Sobata R, Hamaguchi I BMC Infect Dis. 2023; 23(1):418.

PMID: 37340346 PMC: 10283183. DOI: 10.1186/s12879-023-08402-w.


Frequency of HTLV-1 seroconversion between pregnancies in Nagasaki, Japan, 2011-2018.

Komatsu N, Iwanaga M, Hasegawa Y, Miura S, Fuchi N, Moriuchi H Front Microbiol. 2022; 13:1036955.

PMID: 36458188 PMC: 9705752. DOI: 10.3389/fmicb.2022.1036955.


RAISING is a high-performance method for identifying random transgene integration sites.

Wada Y, Sato T, Hasegawa H, Matsudaira T, Nao N, Coler-Reilly A Commun Biol. 2022; 5(1):535.

PMID: 35654946 PMC: 9163355. DOI: 10.1038/s42003-022-03467-w.


Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR.

Rodrigues E, Salustiano S, Santos E, Slavov S, Picanco-Castro V, Maconetto J J Neurovirol. 2022; 28(1):27-34.

PMID: 35025066 DOI: 10.1007/s13365-020-00924-2.


Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Rosadas C, Brites C, Arakaki-Sanchez D, Casseb J, Ishak R Rev Soc Bras Med Trop. 2021; 54(suppl 1):e2020605.

PMID: 34008723 PMC: 8210483. DOI: 10.1590/0037-8682-605-2020.


References
1.
Sobata R, Matsumoto C, Uchida S, Suzuki Y, Satake M, Tadokoro K . Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1. Vox Sang. 2015; 109(2):122-8. DOI: 10.1111/vox.12263. View

2.
Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S . Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol. 2003; 25(2):111-7. DOI: 10.1046/j.1365-2257.2003.00503.x. View

3.
Satake M, Yamaguchi K, Tadokoro K . Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2011; 84(2):327-35. DOI: 10.1002/jmv.23181. View

4.
Kamihira S, Yamano Y, Iwanaga M, Sasaki D, Satake M, Okayama A . Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study. Cancer Sci. 2010; 101(11):2361-7. PMC: 11159861. DOI: 10.1111/j.1349-7006.2010.01720.x. View

5.
Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh K . Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010; 116(8):1211-9. DOI: 10.1182/blood-2009-12-257410. View